Search by Drug Name or NDC

    NDC 57665-0101-41 ABELCET 5; 3.4; 1.5 mg/mL; mg/mL; mg/mL Details

    ABELCET 5; 3.4; 1.5 mg/mL; mg/mL; mg/mL

    ABELCET is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leadiant Biosciences, Inc.. The primary component is AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-.

    Product Information

    NDC 57665-0101
    Product ID 57665-101_0aab355d-bbe3-5a46-e063-6294a90a971f
    Associated GPIs 11000010301820
    GCN Sequence Number 024440
    GCN Sequence Number Description amphotericin B lipid complex VIAL 5 MG/ML INTRAVEN
    HIC3 W3A
    HIC3 Description ANTIFUNGAL ANTIBIOTICS
    GCN 07382
    HICL Sequence Number 010219
    HICL Sequence Number Description AMPHOTERICIN B LIPID COMPLEX
    Brand/Generic Brand
    Proprietary Name ABELCET
    Proprietary Name Suffix n/a
    Non-Proprietary Name amphotericin b, dimyristoylphosphatidylcholine, dl- and dimyristoylphosphatidylglycerol, dl-
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 5; 3.4; 1.5
    Active Ingredient Units mg/mL; mg/mL; mg/mL
    Substance Name AMPHOTERICIN B; DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL-; DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-
    Labeler Name Leadiant Biosciences, Inc.
    Pharmaceutical Class Lipid-based Polyene Antifungal [EPC], Polyene Antifungal [EPC], Polyenes [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050724
    Listing Certified Through 2024-12-31

    Package

    NDC 57665-0101-41 (57665010141)

    NDC Package Code 57665-101-41
    Billing NDC 57665010141
    Package 1 VIAL in 1 CARTON (57665-101-41) / 20 mL in 1 VIAL
    Marketing Start Date 2010-10-18
    NDC Exclude Flag N
    Pricing Information N/A